Clinical manifestations and pathogenesis of dialysis-related amyloidosis

Seminars in Dialysis

Volumn 9, Issue 4, 1996, Pages 360-368

  Sprague, Stuart M ^a,c   Moe, Sharon M ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EVANSTON HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000433063     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139x.1996.tb00699.x     Document Type: Article

References (115)

1. Benz RL, Siegfried JW, Teehan BP: Carpal tunnel syndrome in dialysis patients: comparison between continuous ambulatory peritoneal dialysis and hemodialysis populations. Am J Kidney Dis 6:473-476, 1988
2. Cornelius F, Bardin T, Faller B, Drueke T: Rheumatic syndromes and beta 2 microglobulin amyloidosis in patients receiving long-term peritoneal dialysis. Arthritis Rheum 32:785-788, 1989
3. 2-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis. Nephron 59:654-657, 1991
4. 2-microglobulin amyloidosis as a complication of chronic renal failure. N Engl J Med 323:1070-1071, 1990
5. 2-microglobulin: the constant chain of HLA-antigens. Eur J Clin Invest 10:293-300, 1980
6. 2-microglobulin. Proc Natl Acad Sci USA 82:4225-4229, 1985
7. 2-microglobulin in neutrophils: An intragranular protein. J Immunol 138:3913-3917, 1987
8. 2-microglobulin. Biochemistry 12:4811-4822, 1973
9. 2-microglobulin on the cell surface. Med Biol 55:74-81, 1977
10. 2-microglobulin by hepatocytes. Eur J Clin Invest 18:343-351, 1988
11. 2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci USA 75:6215-6219, 1978
12. 2-microglobulin but not of transferrin receptors on K562 cells. Cell Immunol 95:195-202, 1985
13. 2-microglobulin in hemodialyzed patients. Nephron 21:260-268, 1978
14. 2-microglobulin during haemodialysis. Nephrol Dial Transplant 2:124-126, 1987
15. Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D: Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 16:251-270, 1979
16. 2-microglobulin. Contrib Nephrol 62:44-53, 1988
17. 2-microglobulin turnover in dialyzed patients. Kidney Int 42:1434-1443, 1992
18. 2-microglobulin: Clinical and immunohistochemical study. Amer J Med 83:419-424, 1987
19. Huaux JP, Noel H, Malghem J, Maldague B, Devogelaer JP, Nagant de Deuxchaisnes C: Erosive azotemic osteoarthropathy: possible role of amyloidosis. Arthritis Rheum 28:1075-1076, 1985
20. Munoz-Gomez J, Gomez-Perez R, Llopart-Buisan E, Sole-Argues M: Clinical picture of the amyloid arthropathy in patients with chronic renal failure maintained on haemodialysis using cellulose membranes. Ann Rheum Dis 46:573-579, 1987
21. Argiles A, Mourad G, Axelrud-Cavadore C, Derancourt J, Adell JJ, Mion C, Cavadore JC: Haemodialysis-associated amyloidosis: Beta-2-microglobulin alone or associated with globulin chains. Clin Sci 73:515-518, 1987
22. 2-microglobulin amyloidosis. Am J Kidney Dis 19:427-432, 1992
23. van Ypersele DeStrihou C, Jadoul M, Malghem J, Maldegue B, Jamart J: Effect of dialysis membrane and patient's age on signs of dialysis related amyloidosis: Kidney Int 39:1012-1019, 1991
24. 2-microglobulin amyloid deposition in the vertebral column. Kidney Int 41:1646-1652, 1992
25. 2-microglobulin-derived amyloidosis: onset, distribution and clinical features in 13 hemodialyzed patients. Nephron 60:274-280, 1992
26. Charra B, Calemard E, Uzan M, Terrat JC, Vanel T, Laurent G: Carpal tunnel syndrome, shoulder pain and amyloid deposits in long-term haemodialysis patients. Proc Eur Dial Transpl Assoc-Eur Renal Assoc 21:291-295, 1985
27. Ullian ME, Hammond WS, Alfrey AC, Schultz A, Molitoris BA: Beta-2-microglobulin-associated amyloidosis in chronic hemodialysis patients with carpal tunnel syndrome. Medicine (Baltimore) 68: 107-115, 1989
28. 2-microglobulin. Biochem Biophys Res Commun 129:701-706, 1985
29. 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med 314:585-586, 1986
30. Munoz-Gomez J, Bergada-Barado E, Gomez-Perez R, Llopart-Buisan E, Subias-Sobrevia E, Rotes-Querol J, Sole-Argues M: Amyloid arthropathy in patients undergoing periodical hemodialysis for chronic renal failure: A new complication. Ann Rheum Dis 44:729-733, 1985
31. 2-microglobulin. Ann Rheum Dis 46:634-637, 1987
32. Munoz-Gomez J, Gomez-Perez R, Sole-Arques M, Llopart-Buisan E: Synovial fluid examination for the diagnosis of synovial amyloidosis in patients with chronic renal failure undergoing haemodialysis. Ann Rheum Dis 46:324-326, 1987
33. McMahon LP, Radford J, Dawborn JK: Shoulder ultrasound in dialysis related amyloidosis. Clin Nephrol 35:227-232, 1991
34. Escobedo EM, Hunter JC, Zink-Brody GC, Andress DL: MR imaging of dialysis-related amyloidosis of the shoulder and hip. Skeletal Radiol (in press)
35. Homma N, Gejyo F, Kobayashi H, Saito H, Sakai S, Suzuki M, Hirasawa Y, Arakawa M: Cystic radiolucencies of carpal bones, distal radius and ulna as a marker for dialysis-associated amyloid osteoarthropathy. Nephron 62:6-12, 1992
36. Miura Y, Ishiyama T, Inomata A, Takeda T, Senna S, Okuyama K, Suzuki Y: Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long-term hemodialysis. Nephron 60: 268-273, 1992
37. Davidson GS, Montanera WJ, Flemming JF, Gentilli F: Amyloid destructive spondylarthropathy causing cord compression: Related to chronic renal failure and dialysis. Neurosurgery 33:519-522, 1993
38. Allain TJ, Stevens PE, Bridges LR: Dialysis myelopathy: Quadriparesis due to extradural amyloid of beta-2-microglobulin origin. Br Med J 296:752-753, 1988
39. Schaffer J, Floege J, Koch KM: Clinical aspects of dialysis-related amyloidosis. Contrib Nephrol 112:90-96, 1995
40. Fuchs A, Jagirdar J, Schwartz IS: Beta-2-microglobulin amyloidosis (AB2M) in patients undergoing long-term hemodialysis. Am J Clin Pathol 88:302-307, 1987
41. Campistol JM, Cases A, Torras A, Sole M, Munoz-Gomez J, Montoliu J, Lopez-Pedret J, Revert LI: Visceral involvement of dialysis amyloidosis. Am J Nephrol 7:390-393, 1987
42. Campistol JM, Sole M, Munoz-Gomez J, Lopez-Pedret J, Revert LI: Systemic involvement of dialysis-amyloidosis. Am J Nephrol 10: 389-396, 1990
43. 2-microglobulin derived amyloidosis in patients who undergo long-term hemodialysis. Arch Pathol Lab Med 118:718-721, 1994
44. 2-microglobulin, with caecal perforation after long-term haemodialysis. Virchow Archiv A Pathol Anat 419:349-353, 1991
45. Choi HSH, Heller D, Picken MM, Sidhu GS, Kahn T: Infarction of intestine with massive amyloid deposition in two patients on long-term haemodialysis. Gastroenterology 96:230-234, 1989
46. Takahashi S, Morita T, Koda Y, Murayama H, Hirasawa Y: Gastrointestinal involvement of dialysis-related amyloidosis. Clin Nephrol 30:168-171, 1988
47. Ikegaya N, Kobayashi S, Hishida A, Kaneko E, Furuhashi M, Maruyama Y: Colonic dilatation due to dialysis-related amyloidosis. Am. J Kidney Dis 35:807-809, 1995
48. Deforges-Lasseur C, Combe C, Cernier A: Destructive spondylarthropathy presenting with progressive paraplegia in a dialysis patient. Recovery after surgical spinal cord decompression and parathyroidectomy. Nephrol Dial Transplant 8:180-184, 1993
49. 2-microglobulin amyloidosis. J Comp Assist Tom 14:1030-1032, 1990
50. Hawkins PN, Lavender JP, Myers MJ, Pepys MB: Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component. Lancet 1:1413-1418, 1988
51. 123I-serum amyloid P component. Lancet 338:335-339, 1991
52. 2-microglobulin. Kidney Int 38:1169-1176, 1990
53. 2-microglobulin-related amyloidosis. Nephron 56:357-363, 1990
54. Cohen AS, Jones LA: Advances in amyloidosis. Curr Opin Rheum 5:62-76, 1993
55. 2-microglobulin is an amyloidogenic protein in man. J Clin Invest 76:2425-2429, 1985
56. 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc Natl Acad Sci USA 83:7098-7912, 1986
57. Argiles A, Mourad G, Kerr PG, Garica M, Collins B, Demaille JG: Cells surrounding haemodialysis associated amyloid deposits are mainly macrophages. Nephrol Dial Transplant 9:662-667, 1994
58. 2-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition. Clin Neph 30:158-163, 1988
59. 2-microglobulin. Biochem Biophy Res Comm 168:1223-1229, 1990
60. 2-microglobulin in amyloid deposits associated with hemodialysis. Kidney Int 36:675-681, 1989
61. 2-microglobulin in AB-amyloid in situ. Kidney Int 43(Suppl 41):S100-S105, 1993
62. 2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92:1243-1252, 1993
63. 2-microglobulin in patients with hemodialysis-associated amyloidosis: Identification of the glycated sites. Biochem 33:12215-12221, 1994
64. Niwa T, Miyazaki S, Katsuzaki T, Tatemichi N, Takei Y, Miyazaki T, Morita T, Hirasawa Y: Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis. Kidney Int 48:771-778, 1995
65. 2-microglobulin. Biochem Biophy Res Comm 131:1063-1068, 1985
66. 2-microglobulin amyloid fibrils in peripheral blood mononuclear cell culture. Am J Path 141:241-247, 1992
67. 2-microglobulin as a new from of amyloid protein in patients undergoing hemodialysis. N Eng J Med 314:585-586, 1986
68. 2-microglobulin kinetics in end-stage renal failure. Kidney Int 39:909-919, 1991
69. 2-microglobulin kinetics during haemodialysis and haemofiltralion. Nephrol Dial Transplant J 1:223-228, 1987
70. 2-microglobulin, and dialysis amyloidosis. Lancet 1:1211, 1986
71. Vandenbroucke DM, Jadoul M, Maldague B, Huaux IP, Noel H, van Ypersele de Strihou C: Possible role of dialysis membrane characteristics in amyloid osteoarthropathy. Lancet 1:1211, 1986
72. 2-Microglobulin kinetics during haemofiltration. Nephrol Dial Transplant 3:784-789, 1988
73. 2-microglobulin deposition rate in uremic patients on hemodialysis using a mathematical kinetic model. Kidney Int 47:1453-1457, 1995
74. 2-microglobulin kinetics: in vivo and in vitro studies. Nephrol Dial Transplant 1988;3:284-290
75. 2-microglobulin on dialysis membranes: comparison of different dialyzers and effects of reuse procedures. Int J Artif Organs 12:373-378, 1989
76. 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration. Nephrol Dial Transplant 4:653-657, 1989
77. Kinke B, Rockel A, Abdelhamid S, Fiegle P, Walb D: Transmembranous transport and adsorption of beta-2-microglobulin during hemodialysis using polysulfone, polyacrylonitrile, polymethymethacrylate and cuprammonium rayon membranes. Int J Artif Organs 12: 697-702, 1989
78. Brunner FP, Brynger H, Ehrich JHH, Fassbinder W, Geerlings W, Rizzoni G, Selwood NH, Tufversch G, Wing AJ: Case control study on dialysis arthropathy: the influence of two different dialysis membranes: data from the EDTA registry. Nephrol Dial Transplant 5: 432-436, 1990
79. Kessler M, Netter P, Maheaut H, Wolf C, Prenat E, Cao Huu T, Gaucher A: Highly permeable and biocompatible membranes and prevalence of dialysis-associated arthropathy. Lancet 1:1092-1093, 1991
80. Aoyagi R, Miura Y, Ishiyama T, Maruyama Y: Influence of dialysis membranes on the development of dialysis associated osteoarthropathy. Kidney Int 43(Suppl 41):S111-115, 1993
81. Chanard J, Bindi P, Lavaud S, Toupance O, Maheut H, Lacour F: Carpal tunnel syndrome and type of dialysis membrane. Dr Med J 298:867-868, 1989
82. 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes. Clin Nephrol 42(Suppl 1):S52-S56, 1994
83. Jahn B, Betz M, Deppisch R, Janssen O, Hansch GM, Ritz E: Stimulation of beta-2-microglobulin synthesis in lymphocytes after exposure to cupraphane dialyzer membranes. Kidney Int 40:285-290, 1991
84. 2-microglobulin, interleukin-2 and tumor necrosis factor. Nephrol Dial Transplant 6(Suppl 2):S61-S63, 1991
85. Zaoui PM, Stone WJ, Hakim RM: Effects of dialysis membranes on beta-2-microglobulin by hemodialysis and hemofiltration: A four year follow up. Biomat Art Cells and Immob Biotech 20:1223-1232, 1992
86. 2-microglobulin. Endocrinology 121: 1198-1200, 1987
87. 2-microglobulin induces calcium efflux from cultured neonatal mouse calvariae. Am J Physiol 263:F540-F545, 1992
88. 2-microglobulin stimulates osteoclastic mediated bone mineral dissolution from neonatal mouse calvariae. Calcium Regulating Hormones Bone Met 11:302-306, 1992
89. 2-microglobulin induced bone mineral dissolution. Kidney Int 47:587-591, 1995
90. Miyasaka N, Sato K, Kitano Y, Higaki M, Nishioka K, Ohta K: Aberrant cytokine production from tenosynovium in dialysis associated amyloidosis. Ann Rheum Dis 51:797-802, 1992
91. 2-microglobulin, a preprotein of hemodialysis-associated amyloidosis. Nephron 53:37-40, 1989
92. 2-microglobulin-like proteins. Science 243:655-657, 1989
93. Murphy G, Hembry RM: Proteinases in rheumatoid arthritis. J Rheumatol 19:S61-S64, 1993
94. 2-microglobulin amyloid deposits. Kidney Int 42:915-923, 1992
95. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1. J Clin Invest 93:521-528, 1994
96. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87:9010-9014, 1990
97. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A: Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science 240:1546-1548, 1988
98. Vlassara H, Brownlenn M, Cerami A: High-affinity receptor-mediated uptake and degradation of glucose-modified proteins: A potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci USA 82:5588-5592, 1985
99. Vlassara H, Moldwawer L, Chan B: Macrophage/monocyte receptor for nonenzymatically glycosylated proteins is up-regulated by cachectin/tumor necrosis factor. J Clin Invest 84:1813-1820, 1989
100. 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: Role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem Biophys Res Commun 210: 1235-1241, 1994
101. 2-microglobulin in the pathogenesis of bone lesions in dialysis associated amyloidosis. Nephrol Dial Transplant (In Press)
102. Jorstad S, Smeby LC, Balstad T, Wideroe E: Removal, generation and adsorption of beta-2-microglobulin during hemofiltration with five different membranes. Blood Purification 6:96-105, 1988
103. Kaiser JP, Hagemann J, Von Herrath D, Schaefer K: Different handling of beta-2-microglobulin during hemodialysis and hemofiltration. Nephron 48:132-13, 1988
104. Schiffl H, D'Agostini D, Held E: Removal of beta-2-microglobulin by hemodialysis and hemofiltration: A four year follow-up. Biomat Art Cells Immob Biotech 320:1223-1232, 1992
105. Clark WR, Macias WL, Molitoris BA, Wang NHL: Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int 48:481-488, 1995
106. 2-microglobulin from plasma specimens of long-term dialysis patients by high-performance immunoaffinity chromatography. Clin Chem 39:277-280, 1993
107. 2-microglobulin using grated affinity adsorbents as therapeutic approach for the treat-ment of hemodialysis patients. J Chromatography B 656:1135-141, 1994
108. 2-microglobulin removal from plasma of patients with chronic renal failure. J Chromatography B 664:97-106, 1995
109. 2-microglobulin with adsorbent column. Artif Organs 17:240-243, 1993
110. Sethi D, Brown EA, Maini RN, Gower PE: Renal transplantation for dialysis arthropathy. Lancet 2:448, 1988
111. Jadoul M, Malghem J, Pirson Y, Maldague B, van Ypoersele De Strihou C: Effect of renal transplantation of the radiological signs of dialysis amyloid osteoarthropathy. Clinical Neph 32:194-197, 1989
112. Campistol JM, Munoz-Gomez J, Oppenheimer F, Ricard MJ, Vilardell J, Andreu J: Renal transplantation for dialysis arthropathy. Transplant Proc 24:118-119, 1992
113. Nelson SR, Sharpstone P, Kingswood JC: Does dialysis-associated amyloidosis resolve after transplantation? Nephrol Dial Transplant 8:369-370, 1993
114. Tan SY, Irish A, Winearls C, Brown E, Gower P, Clutterbuck EJ, Madhoo S, Lavender JP, Pepys MB, Hawkins PN: Long-term outcome of renal transplantation on dialysis-related amyloid deposits and disease symptomatology: A prospective 5 year study. J Am Soc Neph (abstract) 5:479, 1994
115. Takenaka R, Fukastu A, Matsuo S, Ishikawa K, Toriyama T, Kawahara H: Surgical treatment of hemodialysis-related shoulder arthropathy. Clin Neph 38:224-230, 1992